GWPH Stock Soars: GW Pharmaceuticals Impresses With Solid Earnings

GWPH stock

GWPH stock is moving up double-digits after GW Pharmaceuticals (NASDAQ:GWPH) reported a big jump in its cannabis-derived epilepsy drug, Epidiolex.

The medicine uses CBD, and it is known to be an effective treatment for some types of epilepsy.

Impressive Quarterly Numbers

As everyone knows, the ultimate aim of many marijuana companies is to manufacture a product that can eventually treat medical conditions, and that ambition received a major boost today after the announcement of GW Pharmaceuticals’ Q2 2019 results. One of the most important products that GW has come up with is a cannabis-based ...

Read The Full Article On PotStockNews.com

Get the latest marijuana stock news, cannabis on stock news on PotStockNews

All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.